dichlororibofuranosylbenzimidazole has been researched along with Milk-Alkali Syndrome in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BenÃtez-Verguizas, J | 1 |
| Esbrit, P | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Milk-Alkali Syndrome
| Article | Year |
|---|---|
Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Antibodies; Bucladesine; Calcium; Carcinoma | 1994 |